Effect of daytime, weekday and year of admission on outcome in acute ischaemic stroke patients treated with thrombolytic therapy

European Journal of Neurology

Volumn 17, Issue 4, 2010, Pages 555-561

  Jauss, M ^a,b   Schutz H J ^c   Tanislav, C ^b   Misselwitz, B ^d   Rosenow, F ^e  

^a Ökumenisches Hainich Klinikum GmbH   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c Eye Hospital   (Germany)

^d Institute of Quality Assurance Hesse   (Germany)

^e UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Cerebral infarction; Delivery of care; Epidemiology; Outcome; Stroke; Thrombolysis

Indexed keywords

ALTEPLASE;

AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DISEASE COURSE; FEMALE; FIBRINOLYTIC THERAPY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; PATIENT ADMISSION; PHOTOPERIOD; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; REGISTRIES; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 77949584809     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02845.x     Document Type: Article

References (33)

1. Hankey GJ, Warlow CP. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet 1999 354 : 1457 1463.
2. Caro JJ, Huybrechts KF, Duchesne I. Management patterns and costs of acute ischemic stroke: an international study. For the Stroke Economic Analysis Group. Stroke 2000 31 : 582 590.
3. Kolominsky-Rabas PL, Heuschmann PU, Marschall D, et al. Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project. Stroke 2006 37 : 1179 1183.
4. Lago A, Geffner D, Tembl J, Landete L, Valero C, Baquero M. Circadian variation in acute ischemic stroke: a hospital-based study. Stroke 1998 29 : 1873 1875.
5. Pasqualetti P, Natali G, Casale R, Colantonio D. Epidemiological chronorisk of stroke. Acta Neurol Scand 1990 81 : 71 74.
6. Turin TC, Kita Y, Murakami Y, et al. Increase of stroke incidence after weekend regardless of traditional risk factors: Takashima Stroke Registry, Japan; 1988-2003. Cerebrovasc Dis 2007 24 : 328 337.
7. Schmidt WP, Taeger D, Buecker-Nott HJ, Berger K. The impact of the day of the week and month of admission on the length of hospital stay in stroke patients. Cerebrovasc Dis 2003 16 : 247 252.
8. Saposnik G, Baibergenova A, Bayer N, Hachinski V. Weekends: a dangerous time for having a stroke? Stroke 2007 38 : 1211 1215.
9. Jauss M, Sitzer M, Stolz E, Misselwitz B, Rosenow F. Lack of increase of cerebrovascular events during German World Cup soccer games in 2006. J Neurol 2009 256 : 863 866.
10. Foerch C, Misselwitz B, Sitzer M, Berger K, Steinmetz H, Neumann-Haefelin T. Difference in recognition of right and left hemispheric stroke. Lancet 2005 366 : 392 393.
11. Jauss M, Allendörfer J, Stolz E, Schütz HJ, Misselwitz B. Treatment results of stroke patients aged >80 years receiving intravenous rt-PA. Cerebrovasc Dis 2007 24 : 305 306.
12. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988 19 : 604 607.
13. Newcombe RG. Improved confidence intervals for the difference between binomial proportions based on paired data. Stat Med 1998 17 : 2635 2650.
14. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007 369 : 275 282.
15. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000 283 : 1145 1150.
16. Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 2005 172 : 1307 1312.
17. Jimenez-Conde J, Ois A, Gomis M, et al. Weather as a trigger of stroke. Daily meteorological factors and incidence of stroke subtypes. Cerebrovasc Dis 2008 26 : 348 354.
18. Lorenzano S, Correnti A, DeMichele M, et al. Circadian, circaseptan and circannual variations of the thrombolytic treatment in acute ischemic stroke. Cerebrovasc Dis 2009 27 (Suppl. 6 87.
19. Marler JR, Price TR, Clark GL, et al. Morning increase in onset of ischemic stroke. Stroke 1989 20 : 473 476.
20. Arboix A, Marti-Vilalta JL. Acute stroke and circadian rhythm. Stroke 1990 21 : 826.
21. Jauss M, Oertel W, Allendoerfer J, Misselwitz B, Hamer H. Bias in request for medical care and impact on outcome during office and non-office hours in stroke patients. Eur J Neurol 2009 16 : 1165 1167.
22. Menon SC, Pandey DK, Morgenstern LB. Critical factors determining access to acute stroke care. Neurology 1998 51 : 427 432.
23. Engelstein E, Margulies J, Jeret JS. Lack of t-PA use for acute ischemic stroke in a community hospital: High incidence of exclusion criteria. Am J Emerg Med 2000 18 : 257 260.
24. Bell CM, Redelmeier DA. Mortality among patients admitted to hospitals on weekends as compared with weekdays. N Engl J Med 2001 345 : 663 668.
25. Kostis WJ, Demissie K, Marcella SW, Shao YH, Wilson AC, Moreyra AE. Weekend versus weekday admission and mortality from myocardial infarction. N Engl J Med 2007 356 : 1099 1109.
26. Ringelstein EB, Meckes-Ferber S, Hacke W, Kaste M, Brainin M, Leys D. European Stroke Facilities Survey: the German and Austrian perspective. Cerebrovasc Dis 2009 27 : 138 145.
27. Heuschmann PU, Berger K, Misselwitz B, et al. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke 2003 34 : 1106 1113.
28. Gropen TI, Gagliano PJ, Blake CA, et al. Quality improvement in acute stroke: the New York State Stroke Center Designation Project. Neurology 2006 67 : 88 93.
29. Koennecke HC, Nohr R, Leistner S, Marx P. Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience. Stroke 2001 32 : 1074 1078.
30. California Acute Stroke Pilot Registry (CASPR) Investigators. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology 2005 64 : 654 659.
31. Sacco RL, DeRosa JT, Haley EC Jr., et al. Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA 2001 285 : 1719 1728.
32. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004 363 : 768 774.
33. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995 333 : 1581 1587.